Safety and Tolerability of Initiating Aripiprazole Lauroxil in Subjects With Schizophrenia Who Are Inadequately Treated With Paliperidone Palmitate or Risperidone Long Acting Injection
Phase of Trial: Phase IV
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Aripiprazole lauroxil (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Alkermes plc
- 10 Aug 2017 Status changed from active, no longer recruiting to completed.
- 01 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2016 Planned number of patients changed from 90 to 50.